Company filings profile · CIK 0001664710
Keros Therapeutics, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Keros Therapeutics, Inc. (KROS): 31 filings in the last 90 days vs 31 in the prior 90 (filing-velocity steady · 1×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Aug 5, 2026. Source-linked, daily-refreshed.
Material 8-K events — Keros Therapeutics, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Aug 3, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Aug 3, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jul 30, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jul 22, 2026 | Departure/Election of Directors or Officers | ↗ |
| Jun 25, 2026 | Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 3, 2026 | Item 5.07 | ↗ |
| Jun 1, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| May 14, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
Watch Keros Therapeutics, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Aug 3, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Aug 3, 2026 | 10-Q | 10-Q | ↗ |
| Aug 3, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jul 30, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jul 29, 2026 | SCHEDULE 13G/A | ↗ | |
| Jul 22, 2026 | 8-K | Departure/Election of Directors or Officers | ↗ |
| Jul 17, 2026 | 4 | ↗ | |
| Jul 17, 2026 | SCHEDULE 13G | ↗ | |
| Jul 6, 2026 | 4 | ↗ | |
| Jul 6, 2026 | 3 | ↗ | |
| Jun 25, 2026 | 8-K | Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 17, 2026 | 4 | ↗ | |
| Jun 15, 2026 | 4 | ↗ | |
| Jun 11, 2026 | 144 | ↗ | |
| Jun 8, 2026 | 4 | ↗ | |
| Jun 8, 2026 | 4 | ↗ | |
| Jun 5, 2026 | 4 | ↗ | |
| Jun 5, 2026 | 4 | ↗ | |
| Jun 5, 2026 | 4 | ↗ | |
| Jun 5, 2026 | 4 | ↗ | |
| Jun 5, 2026 | 4 | ↗ | |
| Jun 5, 2026 | 4 | ↗ | |
| Jun 4, 2026 | 144 | ↗ | |
| Jun 4, 2026 | 144 | ↗ | |
| Jun 4, 2026 | 144 | ↗ | |
| Jun 3, 2026 | 8-K | Item 5.07 | ↗ |
| Jun 1, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| May 19, 2026 | 4 | ↗ | |
| May 15, 2026 | SCHEDULE 13G | ↗ | |
| May 14, 2026 | 10-Q | 10-Q | ↗ |
| May 14, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Apr 22, 2026 | ARS | ARS | ↗ |
| Apr 22, 2026 | DEFA14A | DEFA14A | ↗ |
| Apr 22, 2026 | DEF 14A | DEF 14A | ↗ |
| Apr 17, 2026 | 4 | ↗ | |
| Apr 7, 2026 | SCHEDULE 13G | ↗ | |
| Apr 6, 2026 | 4 | ↗ | |
| Mar 31, 2026 | 144 | ↗ | |
| Mar 27, 2026 | 4/A | ↗ | |
| Mar 27, 2026 | SCHEDULE 13G/A | ↗ |